-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Although opioids have potent analgesic properties, their use is associated with side effects, including opioid-induced constipation (OI.
Recently, a research article was published in Pain and Therapy, an authoritative journal in the field of anesthesia pa.
diagnosis
Researchers surveyed patients over the age of 20 living in Japan via the Internet; they were using opioid or non-opioid analgesics (500 each) for chronic noncancerous musculoskeletal pain (low back pain or osteoarthritis) At least 3 months and provide an electronic letter of consent to participate and complete the surv.
Among patients using opioid analgesics, 89% were taking weak opioi.
CONCLUSIONS : Treatment of chronic noncancerous musculoskeletal pain with opioid analgesics, including weak opioids, is associated with O.
Treatment of chronic noncancerous musculoskeletal pain with opioid analgesics, including weak opioids, is associated with O.
Original source:
Motoki Sonoha.
Motoki Sonoha.
et .
A Survey of the Incidence of Constipation in Patients with Chronic Non-cancer Pain Using Opioid Analgesics in Japa.
Pain and Thera.
202https://li.
spring.
com/article/11007/s40122-022 -00392-y A Survey of the Incidence of Constipation in Patients with Chronic Non-cancer Pain Using Opioid Analgesics in JapanLeave a comment here
